Skip to content

Similarweb

US · SMWB #3491 by market cap Listed 2021
9.05 +0.62 +7.35%
Live - 5344 symbols - heartbeat 149s ago · 2026-10-09 19:59

✦ Quant Financial Health how this is computed

Weak
  • Altman Z-Score is 0.46, below the 1.8 "distress zone" threshold.
  • Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.

Revenue annual, last 7 years

Latest year +13.08% YoY

Margins

Gross margin
79.55%
Operating margin
-8.34%
Net margin
-11.65%

Key ratios & quality

Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.

Income statement

Line item 2019 2020 2021 2022 2023 2024 2025
Revenue 70.59M93.49M137.67M193.23M218.02M249.91M282.60M
Gross profit 50.08M72.07M105.92M139.96M170.93M195.10M224.80M
Selling & admin expenses 49.98M69.66M127.65M167.91M143.58M149.17M175.76M
Research & development 16.21M22.09M44.38M59.90M56.16M55.60M72.60M
Operating profit -16.11M-19.67M-66.11M-87.86M-28.81M-9.66M-23.56M
Pretax profit -17.25M-21.36M-68.00M-83.15M-27.87M-9.53M-28.77M
Tax 458.00K640.00K981.00K516.00K1.51M1.93M4.16M
Net profit -17.71M-22.00M-68.98M-83.66M-29.37M-11.46M-32.94M
Basic EPS 00-1-1000
Diluted EPS -0.27-0.35-1.30-1.10-0.38-0.14-0.39

Balance sheet

Line item 2019 2020 2021 2022 2023 2024 2025
Total current assets 33.00M88.25M187.69M142.18M146.39M141.36M150.34M
Cash & ST investments 7.48M53.94M128.88M77.81M71.73M63.87M72.42M
Inventory --------------
Total assets 45.96M103.63M227.00M246.05M239.01M242.91M261.15M
Total current liabilities 75.49M108.36M134.15M180.93M184.19M177.19M196.57M
Short-term debt 16.85M26.85M--34.09M32.10M6.92M8.84M
Long-term debt --------------
Total liabilities 79,171,000.00112,884,000.00142,085,000.00224,094,000.00223,466,000.00215,403,000.00237,819,000.00
Total equity -33.21M-9.25M84.91M21.95M15.55M27.51M23.33M
Retained earnings -148.27M-171.09M-240.07M-323.73M-353.10M-364.56M-397.49M

Cash flow

Line item 2019 2020 2021 2022 2023 2024 2025
Operating cash flow -9.69M-3.76M-27.63M-46.07M-3.04M30.17M14.64M
Depreciation & amortization 1.78M1.96M3.17M10.58M10.26M10.53M8.99M
Free cash flow -11.50M-4.90M-30.74M-77.24M-5.42M27.44M12.99M
Dividends paid --------------
Stock buybacks / issuance 00150.94M--------
Ending cash balance 7.03M23.94M128.88M77.81M71.73M63.87M72.42M

Returns & efficiency

Line item 2019 2020 2021 2022 2023 2024 2025
ROE % -------156.57-156.66-53.22-129.58
ROA % -38.52-30.51-41.73-35.37-12.11-4.75-13.07
ROIC % -------65.57-32.80-15.39-49.21
5-year avg ROE % --------------
EBIT margin % -22.82-21.04-48.02-45.47-13.21-3.87-8.34
FCF / sales % ----------10.984.60
Current ratio 0.440.811.400.790.790.800.76
Quick ratio 0.350.741.200.650.660.650.65
Debt / assets 36.6625.910.0030.1428.2116.3616.58
LT debt / equity ------182.57227.24119.27147.71
Interest coverage -14.17---34.96--------
Revenue CAGR (3Y) % ------39.8932.6121.9913.51
Net income CAGR (3Y) % --------------
FCF CAGR (3Y) % --------------

Revenue breakdown most recent period

Business

Single segment100.00%

Quote time 2026-10-09 19:59:22 · For reference only, not investment advice and not tailored to your situation.

Similarweb discussion 0 comments

Add a comment